108 related articles for article (PubMed ID: 3162903)
1. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
Dobbs BR; Gazeley LR; Stewart IA; Edwards IR
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
[TBL] [Abstract][Full Text] [Related]
3. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
[TBL] [Abstract][Full Text] [Related]
4. Enoxacin distribution in human tissues after multiple oral administration.
Malmborg AS; Rannikko S
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():57-60. PubMed ID: 3162902
[TBL] [Abstract][Full Text] [Related]
5. [Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man].
Morel C; Vergnaud M; Malbruny B; Benard Y
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):781-4. PubMed ID: 3309815
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of pelvic tissue concentrations after oral administration of enoxacin.
Bates SA; Elder MG
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():79-85. PubMed ID: 3162905
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
[TBL] [Abstract][Full Text] [Related]
8. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.
Davies BI; Maesen FP; Teengs JP
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():83-9. PubMed ID: 6594325
[TBL] [Abstract][Full Text] [Related]
9. Penetration of enoxacin into bronchial secretions.
Fong IW; Vandenbroucke A; Simbul M
Antimicrob Agents Chemother; 1987 May; 31(5):748-51. PubMed ID: 3475036
[TBL] [Abstract][Full Text] [Related]
10. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
Kovarik JM; Hoepelman AI; Smit JM; Sips PA; Rozenberg-Arska M; Glerum JH; Verhoef J
Antimicrob Agents Chemother; 1992 Nov; 36(11):2458-61. PubMed ID: 1336948
[TBL] [Abstract][Full Text] [Related]
11. Bone penetration of enoxacin in patients with and without osteomyelitis.
Fong IW; Rittenhouse BR; Simbul M; Vandenbroucke AC
Antimicrob Agents Chemother; 1988 Jun; 32(6):834-7. PubMed ID: 3166359
[TBL] [Abstract][Full Text] [Related]
12. The effect of age on the pharmacokinetics of enoxacin.
Dobbs BR; Gazeley LR; Campbell AJ; Edwards IR
Eur J Clin Pharmacol; 1987; 33(1):101-4. PubMed ID: 3480221
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue.
Hamel B; Mottet N; Audran M; Costa P; Bressolle F
J Antimicrob Chemother; 2000 Dec; 46(6):993-6. PubMed ID: 11102420
[TBL] [Abstract][Full Text] [Related]
14. [Enoxacin concentration in human prostatic tissue].
Yasumoto R; Kobayakawa H; Asakawa M
Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
Wise R; Griggs D; Andrews JM
Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of enoxacin in elderly patients.
Wise R; Baker SL; Misra M; Griggs D
J Antimicrob Chemother; 1987 Mar; 19(3):343-50. PubMed ID: 3471751
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.
Gee T; Andrews JM; Ashby JP; Marshall G; Wise R
J Antimicrob Chemother; 2001 Apr; 47(4):431-4. PubMed ID: 11266415
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies on interaction between theophylline and quinolones.
Takagi K; Hasegawa T; Ogura Y; Suzuki R; Yamaki K; Watanabe T; Kitazawa S; Satake T
J Asthma; 1988; 25(2):63-71. PubMed ID: 3182580
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.
Marchbanks CR; Mikolich DJ; Mayer KH; Zinner SH; Dudley MN
Antimicrob Agents Chemother; 1990 Oct; 34(10):1966-72. PubMed ID: 2291662
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing.
Begg EJ; Robson RA; Saunders DA; Graham GG; Buttimore RC; Neill AM; Town GI
Br J Clin Pharmacol; 2000 Jan; 49(1):32-8. PubMed ID: 10606835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
